Neil J. Shah

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Phase II Trial of Cabozantinib Plus Nivolumab in Patients With Non–Clear-Cell Renal Cell Carcinoma and Genomic Correlates

Chung‐Han Lee, Martin H. Voss, Maria I. Carlo et al. · Journal of Clinical Oncology · 2022 · 195 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection

Neil J. Shah, Ghassan Al‐Shbool, Matthew Blackburn et al. · Journal for ImmunoTherapy of Cancer · 2019 · 120 citations · Full text

Life Sciences, Immunology, Oncology +17

Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors

Anita Gul, Tyler F. Stewart, Charlene Mantia et al. · Journal of Clinical Oncology · 2020 · 97 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Product review on the Anti-PD-L1 antibody atezolizumab

Neil J. Shah, William Kelly, Stephen V. Liu et al. · Human Vaccines & Immunotherapeutics · 2017 · 71 citations · Full text

Medicine, Oncology, Pharmacology +16